The Jordan Center for
Pharmaceutical Research
About Us
About Us
The Jordan Center for Pharmaceutical Research (JCPR) is a private, fully independent Clinical Research Organization (CRO) founded in 1999 by Prof. Tawfiq Arafat—a distinguished pharmaceutical chemistry expert and former Dean of the Faculties of Pharmacy and Medical Sciences at both the University of Jordan and the University of Petra.
For over two decades, JCPR has provided comprehensive clinical research and trial execution across all phases, supporting pharmaceutical, biotechnology, and medical device sponsors with scientifically rigorous, regulator-ready solutions. Our organization has successfully executed more than 1,200 studies, backed by a volunteer database of 10,000+ healthy male and female participants—ensuring efficient recruitment and reliable timelines.
As one of the first accredited CROs in the MENA region, JCPR integrates deep regional expertise with international regulatory compliance. Our clinical operations are supported by two dedicated research units with 130 total beds, including a 50-bed female-only facility staffed entirely by female professionals to ensure comfort, privacy, and cultural sensitivity.
JCPR’s scientific capabilities are further strengthened by our state-of-the-art bioanalytical laboratory featuring advanced LC-MS/MS platforms from API by SCIEX and Shimadzu, with over 300 validated methods. We also offer specialized preclinical research support and pharmacogenomics and biomarker services, enabling translational research and precision medicine approaches to optimize trial design and patient stratification.
All operations adhere to ICH-GCP, GLP, EMA, FDA, and regional regulatory standards, supported by experienced multidisciplinary teams committed to delivering high-integrity data, operational excellence, and sponsor success across every phase of development.
To learn more about JCPR Please Download Our Brochure Below
Meet The Founder
Dr. (Prof.) Tawfiq Arafat is recognized as one of the leading pioneers in the field of pharmaceutical and medical sciences in the Middle East. He obtained his Ph.D. from Cardiff University (UK) in 1980 and, upon returning to Jordan, played a key role in establishing the first Faculty of Pharmacy at the University of Jordan, where he later served as Dean (1991).
In 1992, Prof. Arafat founded the Faculty of Pharmacy and Medical Sciences at Petra University, which went on to become one of the region’s most reputable schools of pharmacy, ultimately earning U.S. accreditation. He continued to serve in academic leadership roles at Petra University until 2017.
In parallel with his academic career, Prof. Arafat began conducting bioequivalence and clinical studies in 1983 and, in 1999, founded the Jordan Center for Pharmaceutical Research (JCPR), one of the first accredited CROs in the MENA region.
Prof. Arafat has authored more than 130 publications in his field and is regarded as one of Jordan’s most accomplished pharmaceutical researchers and scientists.
​
He has also held several scientific and advisory roles, including:
• Member of the Board of Trustees in University of Jordan (2014)
• Member of the Higher Scientific Committee at the Shoman Institute (2017)
• Principal Investigator of Bioequivalence Studies
• Member of the Clinical Committee at JFDA
• Consultant for the Arab Union of Pharmaceutical Industries
• Vice President at Petra University
• Consultant & Reviewer for the Ministry of Health (Jordan) for subjects related Bioavailability & Bioequivalence studies .
What Sets Us Apart
Years in
the market
Over 26 years in the market.
Healthy
volunteers
Over 10000 healthy volunteers.
Studies Conducted
Over 1200 Studies Conducted.
Validated
assays
Over 300 validated
assays.
Why Choose JCPR
JCPR offers sponsors a rare combination of regulatory credibility, execution reliability, and institutional independence. Clinical trials conducted by JCPR have been successfully reviewed and accepted by both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), reflecting consistent compliance with the world’s most stringent regulatory standards.
JCPR’s leadership has played a formative role in shaping the regional clinical research landscape. The earliest parliamentary legislation regulating Bioequivalence studies in the MENA region was developed based on the scientific leadership and regulatory contributions of Prof. Tawfiq Arafat, later forming the basis for BE and clinical trial regulations adopted by multiple countries. This legacy positions JCPR not only as a service provider, but as a trusted contributor to regulatory frameworks.
As a fully independent CRO with no external shareholders or investor pressure, JCPR reinvests the majority of its resources into quality systems, operational excellence, bioanalytical advancement, and senior scientific oversight—translating into lower execution risk, stable teams, and consistent outcomes for sponsors.
Work Ethics
Ethics without exception.
Human subject safety, rights, and data integrity come first—always.
Efficiency
Speed with discipline.
Optimized systems deliver fast execution without compromising quality.
Accountability
Clear ownership, clear outcomes.
Accurate data, transparent reporting, delivered on time.
Experience
Proven leadership since 1999.
Decades of expertise, hundreds of successful studies.
Our Team
JCPR’s team is built on a strong foundation of expertise, collaboration, and commitment to quality. Our staff includes highly trained professionals with more than 25 years of experience in clinical research, bioanalysis, statistics, and regulatory compliance. Continuous training and education ensure that every study is executed with precision and scientific rigor.
To further strengthen our capabilities, JCPR collaborates with specialized consultants based in Canada, the United Kingdom, and the United States. These partnerships support advanced data management services, including expertise in SAAS, WinNonLin, and other statistical and analytical platforms—ensuring robust, validated, and internationally compliant study outputs.
In addition, JCPR maintains an ongoing collaboration with an external IT consultancy to continually enhance, automate, and secure our operational systems, resulting in greater efficiency and reliability across all clinical and analytical workflows
Principal Investigator and General Manager
Prof. Dr. Tawfiq Arafat
Principal Investigator and General Manager Prof. Dr. Tawfiq Arafat, Professor of Pharmaceutical Analysis, Dean of Pharmacy Faculty in Petra University previously.
Team of Investigators
Team of investigators include General Practitioners (GPs) and specialized physicians and Nurses in different medical branches.
Team of
GCP & GLP professionals
Well trained GCP & GLP professionals and Technicians.
Team of
QA/QC
Highly experienced Quality Assurance and Quality Control teams.
Team of development & Marketing
Newly established department for Business Development and Marketing to ensure that both our clients and staff are always provided with the best services available and constant development to our work and systems.
